Key result
Enalapril, lisinopril, perindopril, and ramipril exhibit linear dose-responses, while benazepril and captopril doses plateau.
Why the study?
What is the dose-response relationship for blood pressure reduction with various ACE inhibitors?
What is the dose-response relationship for blood pressure reduction with various ACE inhibitors?
Current recommended doses for some ACE inhibitors may be higher than necessary, suggesting a need for careful dose initiation in sensitive patients.
Answers are grounded in this paper and cite their sources.
May support lower starting doses for benazepril and captopril; leaves open optimal ACE inhibitor dosing in prospective trials.
UNLABELLED: CURRENT USAGE: Plasma angiotensin converting enzyme (ACE) inhibition and dose-response relationships during blood pressure reductions were compared for several marketed ACE inhibitor compounds. Both peak and trough responses are considered and contrasted. The presently recommended antihypertensive doses of enalapril, lisinopril, perindopril and ramipril appear to lie within the linear range of the antihypertensive dose-response relationship. For benazepril and captopril, the recommended doses may be in the flat, upper part of the relationship. RECOMMENDATIONS: The recommended doses for initiating antihypertensive therapy may still be excessive in patients at risk of heightened pharmacodynamic responses. Further studies are required to clarify the dose-response relationship for all of these compounds.
No takes yet. Share an insight, caveat, or question.
Kennedy R. Lees (1992) conducted a review in Hypertension. Angiotensin converting enzyme (ACE) inhibitors was evaluated. Recommended antihypertensive doses of enalapril, lisinopril, perindopril, and ramipril lie within the linear dose-response range, whereas benazepril and captopril doses may be in the flat upper part.
Synapse has enriched 10 related papers. Consider them for comparative context: